Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.61+0.02 (+3.06%)
Close on Nov 17, 2026Market cap $3.44MP/E –Yield –
Imunon price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Imunon's price to sales ratio was 127.0× on Jan 31, 2024, against 292.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 127.0× | −39.1 |
| 2023 | Dec 29, 2023 | 166.2× | −83.8 |
| 2022 | Dec 30, 2022 | 250.0× | −160.0 |
| 2020 | Oct 30, 2020 | 410.0× | – |
See a number that looks wrong?